Bank of America Initiates Coverage on Sabra Health Care REIT (SBRA)
Research analysts at Bank of America began coverage on shares of Sabra Health Care REIT (NASDAQ:SBRA) in a report released on Monday. The firm set a “neutral” rating and a $29.00 price target on the stock. Bank of America’s price objective indicates a potential upside of 0.66% from the stock’s previous close.
Shares of Sabra Health Care REIT (NASDAQ:SBRA) opened at 28.81 on Monday. Sabra Health Care REIT has a one year low of $21.55 and a one year high of $32.40. The stock’s 50-day moving average is $29.28 and its 200-day moving average is $27.56. The company has a market cap of $1.130 billion and a price-to-earnings ratio of 162.69.
Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Monday, May 5th. The company reported $0.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.01. The company had revenue of $40.85 million for the quarter, compared to the consensus estimate of $35.75 million. During the same quarter in the previous year, the company posted $0.47 earnings per share. Analysts expect that Sabra Health Care REIT will post $2.27 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, May 30th. Stockholders of record on Thursday, May 15th will be paid a dividend of $0.38 per share. This represents a $1.52 annualized dividend and a dividend yield of 5.28%. The ex-dividend date is Tuesday, May 13th. This is a boost from Sabra Health Care REIT’s previous quarterly dividend of $0.36.
SBRA has been the subject of a number of other recent research reports. Analysts at Raymond James reiterated an “outperform” rating on shares of Sabra Health Care REIT in a research note on Thursday, May 8th. They now have a $32.00 price target on the stock, up previously from $31.00. Separately, analysts at TheStreet downgraded shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research note on Thursday, May 8th. Finally, analysts at Stifel Nicolaus raised their price target on shares of Sabra Health Care REIT from $31.00 to $32.00 in a research note on Tuesday, May 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. Sabra Health Care REIT presently has a consensus rating of “Hold” and an average target price of $31.60.
Sabra Health Care REIT, Inc (NASDAQ:SBRA) as a wholly owned subsidiary of Sun Healthcare Group, Inc, a provider of nursing, rehabilitative and related specialty healthcare services to the senior population in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.